HIV Dynamics and Replication Program
About Our Program
The HIV Dynamics and Replication Program (HIV DRP) was formed in 1997 as the HIV Drug Resistance Program, with the mission of conducting and fostering multidisciplinary basic, translational, and clinical research focused on problems related to drug-resistant HIV.Â
The scope of research conducted by HIV DRP scientists has expanded over the years to encompass a broader range of important problems in virus biology. Thus, in 2015, the name of the Program was changed to HIV Dynamics and Replication to better capture the breadth of the research carried out by the Program. Read more...
Investigators
Recent Publications
- Efficient HIV-1 in vitro reverse transcription: optimal capsid stability is required
- Mechanistic analysis of the broad antiretroviral resistance conferred by HIV-1 envelope glycoprotein mutations
- Oncogenic HPV promotes the expression of the long noncoding RNA lnc-FANCI-2 through E7 and YY1
- Structure-based non-nucleoside inhibitor design: Developing inhibitors that are effective against resistant mutants
- Specific guanosines in the HIV-2 leader RNA are essential for efficient viral genome packaging
- PSGL-1 Inhibits the incorporation of SARS-CoV and SARS-CoV-2 spike glycoproteins into pseudovirions and impairs pseudovirus attachment and infectivity
- Opposing activities of IFITM proteins in SARS-CoV-2 infection
- Structural mimicry drives HIV-1 Rev-mediated HERV-K expression
Upcoming Events
Jan
26
2021
Virtual
4:00 PM - 5:00 PM
Jan
27
2021
Feb
9
2021
Feb
23
2021